NASDAQ: LXRX
2.21
+0.03 (+1.38%)
| Range | 2.13 - 2.23 |
| Open | 2.18 |
| Prev Close | 2.18 |
| 52 Week | 1.45 - 3.28 |
| Volume | 996287 |
| Market Cap | 1.134B |
*Delayed 5/17/2013 4:00 EDT
Building a Biopharmaceutical Company
Lexicon Pharmaceuticals is a biopharmaceutical company focused on discovering breakthrough treatment for human disease.
| Stock Quote | Events & Webcasts | ||||||||||||
|
NASDAQ: LXRX
2.21
+0.03 (+1.38%)
*Delayed 5/17/2013 4:00 EDT
|
|
Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000